Terfenadine-induced torsade de pointes: Risk factors and mechanisms

Journal of Pharmacy Technology

Volumn 13, Issue 3, 1997, Pages 127-132

  Chan, Thomas Y K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; ITRACONAZOLE; KETOCONAZOLE; TERFENADINE; TROLEANDOMYCIN;

ARTICLE; DISEASE PREDISPOSITION; DRUG METABOLISM; DRUG OVERDOSE; HUMAN; HYPOKALEMIA; ISCHEMIC HEART DISEASE; LIVER DISEASE; LONG QT SYNDROME; TORSADE DES POINTES;

EID: 0030920496     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512259701300306     Document Type: Article

References (36)

1. McTavish D, Goa KL, Ferrill M. Terfenadine: an updated review of its pharmacological properties and efficacy. Drugs 1990;39:552-74.
2. 1-receptor antagonists: comparative tolerability and safety. Drug Saf 1994;10:350-80.
3. Yun CH, Okerholm RA, Guengerich FP. Oxidation of the antihistaminic drug terfenadine in human liver microsomes: role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos 1993;21:403-9.
4. Davies AJ, Harindra V, McEwan A, Ghose RR. Cardiotoxic effect with convulsions in terfenadine overdose. BMJ 1989;298:325.
5. Bastecky J, Kvasnicka J, Vortel J, Tauchman M, Wasylivova V. Severe antihistamine poisoning complicated by ventricular tachycardia. Vnitr Lek 1990;36:266-9.
6. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR. Torsade de pointes occurring in association with terfenadine use. JAMA 1990;264:2782-90.
7. MacConnell TJ, Stanners AJ. Torsade de pointes complicating treatment with terfenadine (letter). BMJ 1991;302:1469.
8. Venturini E, Borghi E, Maurini V, Vecce R, Carnicelli A. Prolongation of the Q-T interval and hyperkinetic ventricular arrhythmias probably induced by terfenadine use in liver cirrhosis patients. Recenti Prog Med 1992;83:21-2.
9. Zimmermann M, Duruz H, Guinand O, Broccard O, Levy P, Lacatis D. Torsade de pointes after treatment with terfenadine and ketoconazole. Eur Heart J 1992;13:1002-3.
10. Fournier P, Pacouret G, Charbonnier B. A new cause of torsade de pointes: combination of terfenadine and troleandomycin. Ann Cardiol Angeiol (Paris) 1993;42:249-5Z
11. Pohjola-Sintonen S, Vitasalo M, Toivonen L, Neuvonen P. Torsade de pointes after terfenadine-itraconazole interaction. BMJ 1993; 306:186.
12. Biglin KE, Faraon MS, Constance TD, Lieh-Lai M. Drug-induced torsade de pointes: a possible interaction of terfenadine and erythromycin (letter). Ann Pharmacother 1994;28:282.
13. Matsis PP, Easthope RN. Torsade de pointes ventricular tachycardia associated with terfenadine. N Z Med J 1994;107:402-3.
14. Koh KK, Rim MS, Yoon J, Kim SS. Torsade de pointes induced by terfenadine in a patient with long QT syndrome. J Electrophysiol 1994;27:343-6.
15. Paris DG, Parente TF, Bruschetta HR, Guzman E, Niarchos AP. Torsade de pointes induced by erythromycin and terfenadine. Am J Emerg Med 1994;12:636-8.
16. Kamisako T, Adachi Y, Nakagawa H, Yamamoto T. Torsade de pointes associated with terfenadine in a case of liver cirrhosis and hepatocellular carcinoma. Int Med 1995;34:92-5.
17. Ng PW, Chan WK, Chan TYK. Torsade de pointes during the concomitant use of terfenadine and cimetidine. Aust NZJ Med 1996; 26:120-1.
18. Woosley RL, Chen YW, Freiman JP, Gillis RA. Mechanism of cardiotoxic actions of terfenadine. JAMA 1993;269:1532-6.
19. Gully C, Riem R. Torsade de pointes caused by the association of terfenadine and erythromycin (letter). Ann Med Interne (Paris) 1994;145:257-8.
20. Barragan Acea A, Garcia Gonzalez M, Rodriguez Gaspar M, de Armas Trujillo D. Ventricular arrhythmia induced by terfenadine treatment (letter). Med Clin (Barc) 1995;104:155.
21. Pratt CM, Hertz RP, Ellis BE, Crowell SP, Louv W, Moye L. Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol 1994;73:346-52.
22. Hanrahan JP, Choo PW, Carlson W, Greineder D, Faich GA, Platt R. Terfenadine-associated ventricular arrhythmias and QTc interval prolongation: a retrospective cohort comparison with other antihistamines among members of a health maintenance organization. Ann Epidemiol 1995;5:201-9.
23. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA 1993;269:1513-8.
24. Fohjola-Sintonen S, Viitasalo M, Toivonen L, Neuvonen P. Itraconazole prevents terfenadine metabolism and increases risk of torsade de pointes ventricular tachycardia. Eur J Clin Pharmacol 1993;45:191-3.
25. Honig PK, Wortham DC, Hull R, Zamani K, Smith JE, Cantilena LR. Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics. J Clin Pharmacol 1993;33:1201-6.
26. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr. Changes in the pharmacokinetics and electrocardiographic phar-macodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-8.
27. Honig PK, Wortham DC, Zamani K, Cantilena LR. Comparison of the effect of the macrolide antibiotics erythromycin, clarithromycin and azithromycin on terfenadine steady-state pharmacokinetics and electrocardiographic parameters. Drug Invest 1994;7: 148-56.
28. von Miltke LL, Greenblatt DJ, Duan SX, Harmatz JS, Shader RI. In vitro prediction of the terfenadine-ketoconazole pharmacokinetic interaction. J Clin Pharmacol 1994;34:1222-7.
29. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine. Eur J Clin Pharmacol 1993;45:41-6.
30. Smith SJ. Cardiovascular toxicity of antihistamines. Otolaryngol Head Neck Surg 1994;111:348-54.
31. Crumb WJ Jr, Wible B, Arnold DJ, Payne JP, Brown AM. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol 1995;47:181-90.
32. Pinney SP Koller BS, Franz MR, Woosley RL. Terfenadine increases the QT interval in isolated guinea pig heart. J Cardiovasc Pharmacol 1995;25:30-4.
33. 1-receptor antagonist astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 1995;76:110-9.
34. Piepho RW. Current status of second-generation antihistamines. Intern Med Alert 1993;15/16:126-7.
35. Ben-David J, Zipes DP. Torsade de pointes and proarrhythmia Lancet 1993;341:1578-82.
36. Inaba T, Nebert DW, Burchell B, Watkins PB, Goldstein JA, Bertilsson L, et al. Pharmacogenetics in clinical pharmacology and toxicity. Can J Physiol Pharmacol 1995;73:331-8.